Abbott Laboratories closed $6.14 below its 52-week high ($121.64), which the company achieved on March 8th.

Abbott Laboratories closed $6.74 below its 52-week high ($121.64), which the company achieved on March 8th.

In this article, we will take a look into Abbott Laboratories's (NYSE:ABT) DCF analysis, a reliable and data-driven approach ...

We recently compiled a list of the 8 Best Dividend Kings To Invest In For Safe Dividend Growth. In this article, we are going ...

Jim Cramer discusses Occidental Petroleum, Cooper Companies, Energy Transfer, Abbott, Kinder Morgan, Advanced Drainage and ...

In a report released today, Suraj Kalia from Oppenheimer maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...

Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $115.6 which represents a slight increase of $0.01 or 0.01% from the prior close of $115.59. The stock opened at $115.13 and ...

Valued at a market cap of $202.6 billion, North Chicago, Illinois-based Abbott Laboratories (ABT) is a global healthcare ...

Investors in Abbott Laboratories (Symbol: ABT) saw new options become available today, for the January 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Abbott Laboratories (NYSE:ABT – Get Free Report) saw a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 12,050,000 shares, a ...